Medical Diagnostics & Clinical Scoring

AIMS (Abnormal Involuntary Movement Scale)

Use the Abnormal Involuntary Movement Scale (AIMS) to assess and track the severity of tardive dyskinesia in patients on neuroleptic medications.

AIMS Total Score
0
Tardive Dyskinesia RiskNo significant movements detected

Calculated locally in your browser. Fast, secure, and private.

AIMS Overview

The Abnormal Involuntary Movement Scale (AIMS) is a critical neurological screening tool used by psychiatrists and medical professionals to detect and monitor the severity of tardive dyskinesia (TD). TD is a potentially irreversible movement disorder caused by long-term exposure to dopamine-receptor blocking agents, primarily antipsychotic medications.

The Examination Procedure

The AIMS test is a structured physical examination where the clinician observes the patient at rest, with arms extended, and during specific distraction maneuvers. The scale rates the severity of abnormal movements on a 5-point scale (0=None, 1=Minimal, 2=Mild, 3=Moderate, 4=Severe) across specific body regions:

  • Facial and Oral Movements (Muscles of facial expression, lips/perioral area, jaw, tongue)
  • Extremity Movements (Upper arms/wrists/fingers, lower legs/knees/toes)
  • Trunk Movements (Neck, shoulders, hips)

Screening for TD

A positive AIMS screen, which suggests the presence of tardive dyskinesia, is typically defined as:

  • A score of 2 (Mild) in two or more of the seven assessed body areas.
  • A score of 3 (Moderate) or 4 (Severe) in just one body area.

Total Score = Sum of movement severity ratings across all body regions

Frequently Asked Questions

Clinical guidelines recommend performing an AIMS assessment before starting any antipsychotic medication to establish a baseline. After that, it should be repeated every 3 to 6 months for older 'typical' antipsychotics, and every 6 to 12 months for newer 'atypical' antipsychotics.

Tardive dyskinesia can become permanent if ignored. However, if caught early via AIMS screening, adjusting the medication dosage, switching to a different antipsychotic, or prescribing VMAT2 inhibitors (like valbenazine) can significantly reduce or eliminate the movements.

No. While it has global assessment questions, AIMS is specifically designed to detect the choreoathetoid movements characteristic of tardive dyskinesia. Other scales, like the Barnes Akathisia Rating Scale (BARS) or the Simpson-Angus Scale (SAS) for parkinsonism, are used for other drug-induced movement disorders.

Related Calculators in Medical Diagnostics & Clinical Scoring

A-a Gradient Calculator

Try It Now

ABCD2 Score for TIA

Try It Now

ABSI (Burn Severity Index)

Try It Now

Absolute Neutrophil Count (ANC)

Try It Now

Aldrete Score for Post-Anesthesia Recovery

Try It Now

Alvarado Score for Acute Appendicitis

Try It Now